Home > Insider Trading > Filing (0000905718-20-000595)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649094	Vaxcyte Inc.	PCVX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1252524	Von Kurt Emster	C/O Vaxcyte, Inc. 353 Hatch Drive Foster City CA 94404		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2020-06-16	2,185,415	$0.00	2,185,415	No	4	C	Indirect	See Footnotes
Common Stock, $0.001 Par Value Per Share	Acquisiton	2020-06-16	1,217,074	$0.00	3,402,489	No	4	C	Indirect	See Footnotes
Common Stock, $0.001 Par Value Per Share	Acquisiton	2020-06-16	454,812	$0.00	3,857,301	No	4	C	Indirect	See Footnotes
Common Stock, $0.001 Par Value Per Share	Acquisiton	2020-06-16	298,917	$0.00	4,156,218	No	4	C	Indirect	See Footnotes
Common Stock, $0.001 Par Value Per Share	Acquisiton	2020-06-16	12,500	$16.00	4,168,718	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.001 Par Value Per Share	Series A Preferred Stock	Disposition	2020-06-16	2,185,415	$0.00	2,185,415	$0.00
Common Stock, $0.001 Par Value Per Share	Series B Preferred Stock	Disposition	2020-06-16	1,217,074	$0.00	1,217,074	$0.00
Common Stock, $0.001 Par Value Per Share	Series C Preferred Stock	Disposition	2020-06-16	454,812	$0.00	454,812	$0.00
Common Stock, $0.001 Par Value Per Share	Series D Preferred Stock	Disposition	2020-06-16	298,917	$0.00	298,917	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Shares are held by ABV VI. Abingworth LLP is the investment manager of ABV VI and has been delegated with all investment and dispositive power over the securities held by ABV VI. Reporting Person is a member of the investment committee of Abingworth LLP, which approves investment and voting decisions by a majority vote, and no individual member has the sole control or voting power over the shares held by ABV VI.
From time to time, the investment committee may delegate investment and voting authority over certain securities held by ABV VI to employees of Abingworth subject to the supervision and oversight of the investment committee, including any limits on such authority imposed by the investment committee in its discretion and the right of the investment committee to revoke such authority at any time. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.
Each share of Series A, Series B, Series C and Series D Preferred Stock was convertible into shares of Common Stock, $0.001 par value per share ("Common Stock") on a one-for-one basis with no expiration date and automatically converted into Common Stock upon the closing of the initial public offering.